Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis--case report.

Folia Microbiologica
Sławomir LetkiewiczA Górski

Abstract

The treatment of three patients suffering from chronic bacterial prostatitis who were qualified for an experimental phage therapy protocol managed at the Phage Therapy Unit in Wrocław is described. They had previously been treated unsuccessfully with long-term targeted antibiotics, autovaccines, and laser biostimulation. Rectal application of phage lysates targeted against Enterococcus faecalis cultured from the prostatic fluid gave encouraging results regarding bacterial eradication, abatement of clinical symptoms of prostatitis, and lack of early disease recurrence.

References

Feb 1, 1991·Fertility and Sterility·P N SchlegelF F Marshall
Apr 4, 2006·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M J H PronkS M Arend
Apr 21, 2006·Asian Journal of Andrology·Jun-Fu ZhouShu-Mei Zhang
Dec 7, 2007·The Urologic Clinics of North America·Brian M Benway, Timothy D Moon
Jul 29, 2008·Folia Microbiologica·K NigutováP Pristas
Jan 31, 2009·The New England Journal of Medicine·Cesar A Arias, Barbara E Murray
Apr 8, 2009·Clinical and Experimental Medicine·Ryszard MiedzybrodzkiAndrzej Górski

❮ Previous
Next ❯

Citations

Apr 12, 2012·Journal of Virology·Young-Duck Lee, Jong-Hyun Park
Nov 21, 2015·Genome Announcements·Leron KhalifaRonen Hazan
Mar 4, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jenny Fernebro
Mar 25, 2011·Virology Journal·Pieter-Jan CeyssensMaya Merabishvili
Feb 16, 2012·Bacteriophage·Stephen T AbedonElizabeth Martin Kutter
Aug 12, 2010·FEMS Immunology and Medical Microbiology·Sławomir LetkiewiczAndrzej Górski
Sep 2, 2016·Frontiers in Microbiology·Katarzyna BocianAndrzej Górski
Sep 16, 2016·Frontiers in Microbiology·Katarzyna BocianAndrzej Górski
Aug 27, 2013·PloS One·Paulina MiernikiewiczAndrzej Górski
Sep 1, 2016·MBio·Breck A DuerkopLora V Hooper
Apr 3, 2019·Vestnik otorinolaringologii·A I KryukovE G Lapenko
Apr 25, 2019·Viruses·Shawna McCallinBenjamin K Chan
May 17, 2019·Journal of Clinical Microbiology·Katherine M Caflisch, Robin Patel
Oct 7, 2019·The Medical Journal of Australia·Aleksandra Petrovic FabijanJonathan R Iredell
Jun 4, 2020·Current Urology Reports·Zhuo Tony SuAmin Sedaghat Herati
Dec 18, 2019·Current Pharmaceutical Biotechnology·Niran Adhikari, Krishna Prasad Acharya
May 31, 2018·Viruses·Andrzej GórskiJacques Scheres
May 20, 2020·Frontiers in Pharmacology·Situ XiongBin Fu
Apr 25, 2018·Antibiotics·UNKNOWN Expert round table on acceptance and re-implementation of bacteriophage therapyD İpek Kurtbӧke
Jul 17, 2018·Frontiers in Microbiology·Andrzej GórskiKaren S Sfanos
Sep 11, 2020·Microorganisms·María A Núñez-SánchezColin Hill
Apr 26, 2021·Biotechnology Advances·Jorge JoãoAna M Azevedo
Aug 26, 2017·Microbiology Spectrum·Stephen T Abedon
Jul 15, 2021·Expert Opinion on Drug Safety·Gianpaolo PerlettiVittorio Magri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.